These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37379152)

  • 1. Nicotinamide for Skin-Cancer Chemoprevention in Transplantation.
    Schmults CD; Jambusaria-Pahlajani A; Ruiz E
    N Engl J Med; 2023 Jun; 388(26):2493. PubMed ID: 37379152
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinamide for Skin-Cancer Chemoprevention in Transplantation.
    Trepanowski N; Kim DY; Hartman RI
    N Engl J Med; 2023 Jun; 388(26):2493-2494. PubMed ID: 37379153
    [No Abstract]   [Full Text] [Related]  

  • 3. Nicotinamide for Skin-Cancer Chemoprevention in Transplantation. Reply.
    Allen NC; Martin AJ; Damian DL
    N Engl J Med; 2023 Jun; 388(26):2494-2495. PubMed ID: 37379154
    [No Abstract]   [Full Text] [Related]  

  • 4. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
    N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide for Skin-Cancer Chemoprevention.
    Drago F; Ciccarese G; Parodi A
    N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinamide for Skin-Cancer Chemoprevention.
    Zhao Y
    N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Damian DL
    N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinamide: New Indications in Dermatology.
    Escudero-Góngora MM; Fernández-Peñas P
    Actas Dermosifiliogr; 2016 Nov; 107(9):777-778. PubMed ID: 27377936
    [No Abstract]   [Full Text] [Related]  

  • 9. Nicotinamide for skin cancer chemoprevention.
    Damian DL
    Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide and skin cancer chemoprevention: The jury is still out.
    Gilmore SJ
    Australas J Dermatol; 2018 Feb; 59(1):6-9. PubMed ID: 29192960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide.
    Minocha R; Martin AJ; Chen AC; Scolyer RA; Lyons JG; McKenzie CA; Madore J; Halliday GM; Damian DL
    J Invest Dermatol; 2019 Feb; 139(2):467-469. PubMed ID: 30244097
    [No Abstract]   [Full Text] [Related]  

  • 12. Nicotinamide for skin cancer chemoprevention in transplant recipients: a critically appraised topic.
    Riddle AO; Jambusaria-Pahlajani A
    Br J Dermatol; 2023 Nov; 189(6):664-665. PubMed ID: 37665964
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK.
    Gollins CE; Shah A; Sinha K; Khan S; Paul N; Meeajun B; Abbott RA; Blasdale C; Cooper H; Harwood CA; Ismail F; Lear JT; Mackintosh L; McCormack S; Perrett CM; Proby CM; Durack A; Patalay R; Matin RN
    Br J Dermatol; 2020 Aug; 183(2):394-396. PubMed ID: 32119116
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
    Minocha R; Damian DL; Halliday GM
    Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
    Nemer KM; Council ML
    Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'.
    Yélamos O; Halpern AC; Weinstock MA
    Br J Dermatol; 2017 Feb; 176(2):551-552. PubMed ID: 27880000
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin cancer: Nicotinamide reduces new skin cancer risk.
    Sidaway P
    Nat Rev Clin Oncol; 2016 Jan; 13(1):4. PubMed ID: 26525684
    [No Abstract]   [Full Text] [Related]  

  • 19. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide found to reduce the rate of nonmelanoma skin cancers in high-risk patients.
    Barton MK
    CA Cancer J Clin; 2016; 66(2):91-2. PubMed ID: 26754863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.